NDC product
Obagi Nu-Derm System Normal-Oily Skin Transformation
NDC 62032-912 · Obagi Cosmeceuticals LLC
Key facts
| Product NDC | 62032-912 |
|---|---|
| Proprietary name | Obagi Nu-Derm System Normal-Oily Skin Transformation |
| Nonproprietary name | HYDROQUINONE, HOMOSALATE, OCTISALATE, ZINC OXIDE |
| Dosage form | KIT |
| Labeler | Obagi Cosmeceuticals LLC |
| Product type | HUMAN PRESCRIPTION DRUG |
| Marketing category | UNAPPROVED DRUG OTHER |
| Marketing start | Jun 25, 2021 |
| Listing certified through | Dec 31, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: